ACIST Pro Debuts in Europe, Marking a New Era in Precision Contrast Management for Cardiovascular Imaging
Published: 13 Feb 2026
Author: Precedence Research
ACIST Medical Systems, Inc. is a subsidiary of Bracco Group and an established pioneer in the development of advanced contrast delivery technologies. The company declared the introduction of the European market of the ACIST Pro Diagnostic System. The next-generation platform will be introduced in the specified European markets after the European Medical Device Regulation (MDR) approval of the CE Mark.
The company aimed at improving the accuracy, safety, and workflow of image-guided cardiovascular procedures. The CE Mark certification confirms that the system has been developed to conform to the strict European Union regulations on safety, health, and environmental protection. This further supports its preparation for clinical adoption in the context of the advanced care system.
ACIST Pro was specifically designed for the interventional cardiology setting. This is the first to offer improved control of contrast, where a clinician can vary the parameters of delivery more accurately during an angiographic procedure. The ability is especially noteworthy in complicated cases where there is a strong necessity to reduce the contrast volume, particularly in high-risk patients who have impaired renal conditions.
ACIST Pro is designed to improve the catheterization laboratory workflow. The system enables interventional teams to be more directly procedural strategy-oriented and patient-centered by minimizing manual handling. Furthermore, the ACIST medical systems have been able to lead the pack in cardiovascular imaging through years of experience in automated contrast management.
Executives Statements
Dr. Fulvio Renoldi Bracco, CEO of Bracco Imaging, emphasized the strategic significance of the launch, stating, The launch of ACIST Pro is an important step in our ongoing effort to advance precision imaging across specialties. By thoughtfully evolving a trusted platform, we are responding to the real-world needs of today’s interventional teams. This milestone reflects our commitment to delivering practical, forward-looking solutions that support quality, safety, and sustainability in diagnostic imaging.
Brad Fox, CEO of ACIST Medical Systems, highlighted the technological progression behind the system, noting, “Building on the trusted ACIST CVi system, ACIST Pro is our next-generation solution, enhancing precision and efficiency in the cardiac catheterization laboratory. With its European launch, we are proud to bring this advanced technology to clinicians and continue our commitment to innovation in interventional imaging.